A Study to Verify if the Surgery for the Proximal Femur Fracture Can be Improved With the Help of a Navigation System
Launched by CHRISTIAN CANDRIAN · Jul 28, 2020
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new system called ADAPT, which helps surgeons perform better surgeries for patients with a specific type of hip fracture known as a proximal femur fracture. The ADAPT system uses special software to create a 3D image of the hip without exposing patients to extra radiation. This technology helps surgeons place screws more accurately and may also make the surgery quicker and safer.
To participate in this study, you need to be between 50 and 85 years old and be having surgery for a hip fracture at a specific hospital in Lugano. You should also have a body mass index (BMI) between 18 and 35 and be able to understand and follow the study procedures. If you join the study, you can expect to receive care that may help improve your surgery experience. However, certain medical conditions or personal circumstances might prevent you from participating, such as severe health issues or difficulties in following the study's requirements.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients undergoing unilateral primary intramedullary nailing at the Ospedale Regionale di Lugano.
- • Patients aged 50-85 years old.
- • Patients with a BMI \>18 and \<35.
- • Patients able to provide informed consent and follow all the study procedures as indicated by the protocol.
- • Radiological evidence of proximal fracture of the femur, AO classified as 31 A1.3, 31 A2.1, 31 A2.2, 31 A2.3, 31 A3.1, 31 A3.2, 31 A3.3.
- Exclusion Criteria:
- • Other clinically significant concomitant disease states (e.g. renal failure, major hepatic dysfunction, life-threatening cardiovascular disease, etc..).
- • Known or suspected non-compliance, drug or alcohol abuse.
- • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant.
- • Previous enrolment into the current study.
- • Enrolment of the investigator, his/her family members, employees and other dependent persons.
About Christian Candrian
Christian Candrian is a dedicated clinical trial sponsor with extensive experience in advancing medical research and innovation. Committed to improving patient outcomes, he oversees the development and implementation of rigorous clinical trials across various therapeutic areas. With a strong focus on ethical practices and regulatory compliance, Christian ensures that all studies adhere to the highest standards of quality and safety. His leadership fosters collaboration among multidisciplinary teams, driving the successful translation of scientific discoveries into effective treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lugano, , Switzerland
Patients applied
Trial Officials
Christian Candrian, MD
Principal Investigator
Ente Ospedaliero Cantonale, Bellinzona
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials